𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug–drug interactions

✍ Scribed by Min-Koo Choi; Qing-Ri Jin; Yeong-Lim Choi; Sung-Hoon Ahn; Myung-Ae Bae; Im-Sook Song


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
232 KB
Volume
32
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Species differences of inhibitory effect
✍ Naoto Suzuyama; Miki Katoh; Toshiyuki Takeuchi; Sumie Yoshitomi; Tomoaki Higuchi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Previously, we clarified the species differences in P-glycoprotein (P-gp)mediated drug transport activity using human MDR1, monkey MDR1, canine MDR1, rat MDR1a, rat MDR1b, mouse mdr1a, and mouse mdr1b transfected LLC-PK 1 cell lines. However, the species differences in the inhibitory effects on P-gp

Gauging the clinical significance of P-g
✍ Bill J. Gurley; Ashley Swain; D. Keith Williams; Gary Barone; Sunil K. Battu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

## Abstract Concomitant administration of botanical supplements with drugs that are P‐glycoprotein (P‐gp) substrates may produce clinically significant herb‐drug interactions. This study evaluated the effects of St. John's wort and __Echinacea__ on the pharmacokinetics of digoxin, a recognized P‐gp

Differential effects of the nonsteroidal
✍ Maria Antonietta Ajmone-Cat; Alessia Nicolini; Luisa Minghetti 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract Increasing experimental, clinical, and epidemiological studies point to the pivotal role of inflammation in the pathogenesis of acute and chronic neurodegenerative diseases and to the protective effects of nonsteroidal antiinflammatory drug (NSAID) therapies. Nonetheless, NSAID long‐ter

ChemInform Abstract: Studies on Disease-
✍ Atsuo Baba; Tsuneo Oda; Shigehisa Taketomi; Kohei Notoya; Atsushi Nishimura; Har 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

Studies on Disease-Modifying Antirheumatic Drugs. Part 3. Bone Resorption Inhibitory Effects of Ethyl 4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) and Related Compounds. -Structure-activity relationships concerning the bone resorption inhibitor